Tsinghua University, Gates Foundation to set up institute on drug discovery

25 January 2016
bill-melinda-gates-big

At a meeting in Davos, Switzerland, last Friday, Qiu Yong, president of Tsinghua University, and Bill Gates, co-chairman of the Bill & Melinda Gates Foundation (BMGF), agreed to co-found the Global Health Drug Discovery Institute (GHDDI) in Beijing, China, and signed a memorandum of understanding.

The Institute will be the first research and development center of its kind in China, and will tackle major diseases faced by many developing countries, including China. No indication of funding for the project was disclosed.

As co-founding partners of GHDDI, BMGF will provide financial support as well as assistance on institutional development, whereas Tsinghua University will invest various resources to support the institute, including talents and scientists, programs, facilities, as well as operation and management.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK



Today's issue

Company Spotlight





More Features in Pharmaceutical